Yale Jen
Stock Analyst at Laidlaw & Co.
(0.02)
# 3,314
Out of 4,412 analysts
12
Total ratings
12.5%
Success rate
-40.03%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INAB IN8bio | Initiates: Buy | $7.5 | $0.99 | +657.58% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $0.87 | - | 2 | Dec 22, 2023 | |
| EVFM Evofem Biosciences | Downgrades: Hold | n/a | $0.01 | - | 2 | Dec 13, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $1.89 | +429.10% | 1 | Aug 28, 2023 | |
| TCRT Alaunos Therapeutics | Downgrades: Hold | n/a | $1.33 | - | 1 | Aug 15, 2023 | |
| BLPH Bellerophon Therapeutics | Downgrades: Hold | n/a | $0.06 | - | 2 | Jun 6, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $6 | $0.14 | +4,137.29% | 1 | Sep 6, 2022 | |
| VINC Vincerx Pharma | Initiates: Buy | n/a | $0.84 | - | 1 | Sep 13, 2021 | |
| SLNO Soleno Therapeutics | Initiates: Buy | n/a | $45.53 | - | 1 | Dec 23, 2019 |
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.99
Upside: +657.58%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.87
Upside: -
Evofem Biosciences
Dec 13, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.01
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $1.89
Upside: +429.10%
Alaunos Therapeutics
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.33
Upside: -
Bellerophon Therapeutics
Jun 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.06
Upside: -
NLS Pharmaceutics AG
Sep 6, 2022
Initiates: Buy
Price Target: $6
Current: $0.14
Upside: +4,137.29%
Vincerx Pharma
Sep 13, 2021
Initiates: Buy
Price Target: n/a
Current: $0.84
Upside: -
Soleno Therapeutics
Dec 23, 2019
Initiates: Buy
Price Target: n/a
Current: $45.53
Upside: -